Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-02-12
2010-10-26
Kosack, Joseph R (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S339000, C514S414000, C544S364000, C546S277400, C548S466000, C548S548000
Reexamination Certificate
active
07820672
ABSTRACT:
The compounds are indolylmaleimide derivatives comprising either a substituted pyridyl or indolyl residue. The compounds have interesting pharmaceutical properties, e.g. in the treatment and/or prevention of T-cell mediated acute or chronic inflammatory diseases or disorders, autoimmune diseases, or acute or chronic transplant rejection.
REFERENCES:
patent: 5057614 (1991-10-01), Davis et al.
patent: 5405864 (1995-04-01), Broka
patent: 5559228 (1996-09-01), Gillig et al.
patent: 40 05 970 (1991-08-01), None
patent: 0 328 026 (1989-08-01), None
patent: 0 540 956 (1993-05-01), None
patent: 2 772 266 (1999-06-01), None
patent: 2 799 200 (2001-04-01), None
patent: 63-24245 (1988-02-01), None
patent: 6-161024 (1994-06-01), None
patent: 9-61647 (1997-03-01), None
patent: 2002-285146 (2002-10-01), None
patent: 93/18765 (1993-09-01), None
patent: 00/21927 (2000-04-01), None
patent: 00/38675 (2000-07-01), None
patent: 01/30331 (2001-05-01), None
patent: 01/46178 (2001-06-01), None
patent: 01/85685 (2001-11-01), None
patent: 02/10158 (2002-02-01), None
patent: 02/38561 (2002-05-01), None
patent: WO 0238561 (2002-05-01), None
patent: 02/078679 (2002-10-01), None
patent: 03/076398 (2003-09-01), None
Patani et al. “Bioisosterism: A Rational Approach in Drug Design” Chemical Reviews, 1996, vol. 96, pp. 3147-3176.
McMurry, John “Organic Chemistry—Fourth Edition” Brooks/Cole Publishing Company, 1996, p. 553.
Von Matt Peter
Wagner Jürgen
Hoxie & Associates LLC
Kosack Joseph R
Novartis AG
LandOfFree
Indolylmaleimide derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indolylmaleimide derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indolylmaleimide derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4203377